# Jinqiao Zhu

> Jinqiao Zhu is a seed investor at EFung Capital backing Medical and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [EFung Capital](https://shizune.co/investors/profile/efung-capital)
- Total investments: 2
- Last investment: Feb 2023
- Lead investor: 100%
- Last updated: Aug 2026

Jinqiao Zhu is a seed investor at EFung Capital focused on Medical and Health Care. Jinqiao Zhu is the founder of EFung Capital.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |
| Medical Device | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series C | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Huayuan Regenerative Medicine | Huayuan Regenerative Medicine is a developer of implantable biological artificial organs. |  | Seed | Feb 08, 2023 |  |
| Raynovent | Raynovent is a science-driven innovative biotech company. | $53.6M | Series C | Dec 30, 2022 |  |

2 of 2 investments shown.

## Co-investors
- [Eide Fund](https://shizune.co/investors/profile/eide-fund) — VC Fund, 1 deal together
- [Guangdong Zhongsheng Pharmaceutical](https://shizune.co/investors/profile/guangdong-zhongsheng-pharmaceutical) — VC Fund, 1 deal together
- [Guangzhou Guoju Venture Capital](https://shizune.co/investors/profile/guangzhou-guoju-venture-capital) — VC Fund, 1 deal together
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund, 1 deal together
- [Lake Bleu Capital](https://shizune.co/investors/profile/lake-bleu-capital) — VC Fund, 1 deal together
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund, 1 deal together

## About EFung Capital

VC Fund · Shenzhen, China

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

4 contacts available at EFung Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Jinqiao Zhu | Founder | https://shizune.co/investors/profile/jinqiao-zhu |
| Luo Fayong | Managing Director | https://shizune.co/investors/profile/luo-fayong |
| Pai Zhu | Managing Partner | https://shizune.co/investors/profile/pai-zhu |
| Yu Wang | Chief Scientist | https://shizune.co/investors/profile/yu-wang-87d2 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Jinqiao Zhu invest in?

Jinqiao Zhu invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Series C stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jinqiao Zhu last invest?

The most recent investment recorded for Jinqiao Zhu closed in Feb 2023. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co